Description
Pluryal Mesoline Clear 5ml is a Mesotherapy treatment designed to regulate sebum, reduce acne and other skin imperfections, and decrease skin inflammation. This product is ideal for young or acne-prone skin of all ages. Pluryal Mesoline Clear Treatments will make the skin surface healthier and more even-looking due to its clarifying qualities.
Buy other Pluryal products hereThe pack consists of:
Composition of the product:
- Vitamin A
- Vitamin B complex
- Hyaluronic acid
- Ginkgo Biloba
Benefits of PLURYAL® MESOLINE CLEAR 5ML
- Reduce and diminish imperfections in the skin
- Ideal for young and acne-prone skin
- Areas: Face and back
How to use the product?
Results with PLURYAL® MESOLINE CLEAR 5ML are immediate and noticeable from the first treatment. For the best and long-lasting results, the treatment should be performed in 5 sessions with a 10-day interval. For maintenance, repeat the procedure every 6 months.
THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)
MANUFACTURER
MD SKIN SOLUTIONS
Brand
PLURYAL
Pluryal offers a wide range of treatments and products to correct signs of skin ageing and rejuvenate the skin with long-lasting and natural looking results. Pluryal is a new generation of hyaluronic acid dermal fillers, skin boosters and mesotherapy. The products in the Pluryal line have been designed to boost the skin, reduce the appearance of facial wrinkles and restore lost volume leaving the skin more radiant, glowing and younger-looking.
MD Skin Solutions introduces a wide range of safe and efficient anti-aging products to meet the specific needs of all age groups. Pluryal dermal fillers are designed to reduce the signs of ageing by reducing wrinkles and restoring volume. Pluryal Booster is a skin booster with an antioxidant formula designed specifically to reduce the appearance of fine lines and tighten the skin for a more glowing appearance. Pluryal Mesoline is a range of bio-revitalization products that effectively rejuvenates and tightens aging skin.
Reviews
There are no reviews yet.